コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 leased by the skin affected by AD (including thymic stromal lymphopoietin).
2 inflammatory markers IL-1, IL-4, IL-13, and thymic stromal lymphopoietin.
3 moderate affinity for IL-7 but does not bind thymic stromal lymphopoietin.
4 prostaglandin E(2), interleukin (IL)-10, and thymic stromal lymphopoietin.
5 feron gamma, tumor necrosis factor alpha, or thymic stromal lymphopoietin.
6 production by activating dendritic cells via thymic stromal lymphopoietin.
7 , IL-1alpha, IL-1beta, CCL20/MIP-3alpha, and thymic stromal lymphopoietin.
8 BLIN-4L could also respond to human thymic stromal lymphopoietin.
9 the interplay with dendritic cells primed by thymic stromal lymphopoietin.
12 als expressed significantly higher levels of thymic stromal lymphopoietin, a major proinflammatory cy
15 e resulting class switching was amplified by thymic stromal lymphopoietin, an epithelial interleukin
16 in(-)CD45R(lo-neg)CD19(+) cells responded to thymic stromal lymphopoietin and 'preferentially' recons
17 ry cytokines and chemokines, including IL-5, thymic stromal lymphopoietin and CCL11, that help to ini
18 on house dust mite (HDM)-induced release of thymic stromal lymphopoietin and GM-CSF from tracheal ep
22 the receptor for the Th2-promoting cytokine thymic stromal lymphopoietin and the high-affinity IgE r
23 cteristics of receptors for IL-4, IL-13, and thymic stromal lymphopoietin and their respective ligand
24 ion of ATP receptor P2X7R, and production of thymic stromal lymphopoietin and type 1, type 2, and typ
25 L-18 receptor 1 (IL1RL1-IL18R1), RAD50-IL13, thymic stromal lymphopoietin and WD repeat domain 36 reg
26 f CCL20/macrophage-inducible protein 3alpha, thymic stromal lymphopoietin, and CCL3-like 1 because of
28 lease cytokines, such as IL-1, IL-25, IL-33, thymic stromal lymphopoietin, and GM-CSF, and endogenous
29 and a reduction in AD-related cytokine IL-8, thymic stromal lymphopoietin, and IL-10 secretion were o
30 ounding, migratory epithelia produce CXCL10, thymic stromal lymphopoietin, and IL-1beta and its antag
32 increased expression of IL-4, IL-13, IL-22, thymic stromal lymphopoietin, and other cytokines associ
33 were those noted in TH2 (IL13, CCL18, CCL26, thymic stromal lymphopoietin, and periostin), TH9/IL-9,
34 the proallergic cytokines IL-1alpha, IL-33, thymic stromal lymphopoietin, and the growth factor amph
35 n of chemokine and cytokine genes, including thymic stromal lymphopoietin; and skin remodeling with f
36 g antibodies against IL-5, IL-13, IL-33, and thymic stromal lymphopoietin, as well as oral chemoattra
37 serum markers (CCL2, CCL5, CCL11, IL-3, and thymic stromal lymphopoietin) at 3 time points (ie, duri
38 of cytokines (interleukin [IL] 25, IL33, and thymic stromal lymphopoietin) by colon tissues, which ac
39 k the function of relevant molecules such as thymic stromal lymphopoietin, chemoattractant-receptor h
42 identified genetic perturbations (eotaxin-3, thymic stromal lymphopoietin, IL-13, and filaggrin) that
43 cells preferentially expressed receptors for thymic stromal lymphopoietin, IL-25, and IL-33 and demon
44 outcomes, with an emphasis on the actions of thymic stromal lymphopoietin, IL-25, and IL-33 at the ep
45 r biologics similarly inhibit TH2 cytokines (thymic stromal lymphopoietin, IL-4, IL-5, IL-13, and the
46 2-associated cytokines (interleukin (IL)-33, thymic stromal lymphopoietin, IL-5 and IL-13), serum imm
47 y inflammatory mediators from AECs including thymic stromal lymphopoietin, IL-6, and PGE2, in part th
48 MCT feeding stimulated jejunal-epithelial thymic stromal lymphopoietin, Il25, and Il33 expression
49 he non-haematopoietic-cell-derived cytokines thymic stromal lymphopoietin, IL33 and IL25 (also known
50 -CSF and chemokines such as CCL2, CCL20, and thymic stromal lymphopoietin in epithelial cells through
52 n of the epithelial-cell-restricted cytokine thymic stromal lymphopoietin in the intestine and, after
54 ion for the Th2-inducing cytokines IL-33 and thymic stromal lymphopoietin in WT mice with colitis, wh
55 and stimulated secretion of IL-8, IL-10, and thymic stromal lymphopoietin independent of PAR2 activit
56 1, VCAM-1, E-selectin, RANTES, IL-17, IL-33, thymic stromal lymphopoietin, inducible NO synthase, and
57 ar destruction, which results in lower serum thymic stromal lymphopoietin levels, milder B-cell lymph
58 itic cells (that have been "educated" by the thymic stromal lymphopoietin molecule produced by a thym
59 esponses and airway pathology, and IL-33 and thymic stromal lymphopoietin most likely play key roles
65 Mice deficient in IL-33R (Il1rl1(-/-)) and thymic stromal lymphopoietin receptor (Tslpr(-/-)) showe
66 ession profiling and to assess the effect of thymic stromal lymphopoietin receptor (TSLPR) blockade i
67 dependently of IL-3 by increasing functional thymic stromal lymphopoietin receptor (TSLPR) expression
72 on expression levels of receptors for TSLP (thymic stromal lymphopoietin receptor [TSLPR] and CD127)
75 rface-activating receptors, such as CD48 and thymic stromal lymphopoietin receptors, as well as inhib
76 f autocrine/paracrine IL-10, IL-4, IL-22 and thymic stromal lymphopoietin regulated these JAK-depende
77 protease-activated receptor 2, resulting in thymic stromal lymphopoietin secretion and a cutaneous T
79 ckout (FcRgamma(-/-)) mice were crossed with thymic stromal lymphopoietin transgenic (TSLPtg) mice, w
80 sin II type 1 receptor blocker (losartan) in thymic stromal lymphopoietin transgenic (TSLPtg) mice, w
81 In addition, administration of imatinib to thymic stromal lymphopoietin transgenic mice with establ
82 tested the protective effects of imatinib in thymic stromal lymphopoietin transgenic mice, a model of
83 P = 0.01), higher mRNA transcript numbers of thymic stromal lymphopoietin (TSLP) (1.6-fold, P = 0.009
84 l roles in allergic inflammation mediated by thymic stromal lymphopoietin (TSLP) (see the related art
85 We evaluated the role of the innate cytokine thymic stromal lymphopoietin (TSLP) acting on mast cells
86 ls that was dependent on the innate cytokine thymic stromal lymphopoietin (TSLP) and also induced ano
87 hat have been epicutaneously sensitized with thymic stromal lymphopoietin (TSLP) and antigen to repea
90 nses are developed simultaneously, driven by thymic stromal lymphopoietin (TSLP) and IL-23, respectiv
91 irements for the epithelial cytokines IL-33, thymic stromal lymphopoietin (TSLP) and IL-25 in the act
94 eosinophilia, as well as increased levels of thymic stromal lymphopoietin (TSLP) and IL-5 in the skin
97 in the blood myeloid compartment as well as thymic stromal lymphopoietin (TSLP) and transforming gro
98 licating hepatic epithelial-derived cytokine thymic stromal lymphopoietin (TSLP) and type 2 immunity,
99 cells was suppressed by anti-IL-1 and anti- thymic stromal lymphopoietin (TSLP) and was enhanced by
100 ymorphisms in the gene encoding the cytokine thymic stromal lymphopoietin (TSLP) are associated with
104 that both genetic and chemical induction of thymic stromal lymphopoietin (TSLP) at a distant site le
106 onstrate that the overproduction of cytokine thymic stromal lymphopoietin (TSLP) by AD skin promotes
107 dized lipids that triggered the induction of thymic stromal lymphopoietin (TSLP) by epithelial cells
108 mice were associated with overproduction of thymic stromal lymphopoietin (TSLP) by IECs, which negat
110 ial cell-derived cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) can promote CD4(+) T
115 rotease inhibitor Kazal-type 5 (SPINK5), and thymic stromal lymphopoietin (TSLP) gene variants and ch
127 monstrate a previously unrecognized role for thymic stromal lymphopoietin (TSLP) in promoting the pop
129 the role of the epithelial-derived cytokine thymic stromal lymphopoietin (TSLP) in the response to R
130 Mice overexpressing the proallergic cytokine thymic stromal lymphopoietin (TSLP) in the skin develop
168 romote the growth and activation of B cells, thymic stromal lymphopoietin (TSLP) is now known to have
173 lls and innate immune cells via the cytokine thymic stromal lymphopoietin (TSLP) is thought to drive
174 ic march suggest that systemic, skin-derived thymic stromal lymphopoietin (TSLP) mediates progression
178 owed that dendritic cells (DCs) activated by thymic stromal lymphopoietin (TSLP) prime naive CD4(+) T
179 We previously showed that mDCs, educated by thymic stromal lymphopoietin (TSLP) produced by the epit
180 triggered by an increased expression of the thymic stromal lymphopoietin (TSLP) proinflammatory cyto
186 Recent studies revealed a critical role for thymic stromal lymphopoietin (TSLP) released from epithe
187 se-activated receptor 2 (PAR2), resulting in thymic stromal lymphopoietin (TSLP) secretion and a cuta
189 component of the receptors for both IL-7 and thymic stromal lymphopoietin (TSLP) suggests that IL-2 c
190 genomic databases, and its homology to mouse thymic stromal lymphopoietin (TSLP) suggests that it is
193 nemia in the development of liver disease in thymic stromal lymphopoietin (TSLP) transgenic mice that
194 genital mucosal epithelial cells to produce thymic stromal lymphopoietin (TSLP) via activation of th
196 e tissue-derived cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) was significantly di
197 el cytokine from a thymic stromal cell line (thymic stromal lymphopoietin (TSLP)) promotes the develo
198 so when ILC2s were stimulated with IL-7 and thymic stromal lymphopoietin (TSLP), 2 ligands of IL-7 r
199 s also proposed to control the activation of thymic stromal lymphopoietin (TSLP), a cytokine implicat
201 with polymorphisms in the gene that encodes thymic stromal lymphopoietin (TSLP), a cytokine that pro
205 rus infection or dsRNA stimulation increased thymic stromal lymphopoietin (TSLP), an upstream pro-all
206 in association with induction of Il33, Csf2, thymic stromal lymphopoietin (Tslp), and Ccl20 transcrip
207 several cytokines (e.g., IL-4, IL-12, IL-23, thymic stromal lymphopoietin (TSLP), and IFNgamma) impli
208 ain innate factors, namely IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), are elaborated by s
209 nd mast cells, a higher expression levels of thymic stromal lymphopoietin (TSLP), cathelicidin, prote
212 s known to activate ILCs (IL-2, IL-7, IL-12, thymic stromal lymphopoietin (TSLP), IL-25, and IL-33).
213 at epithelial cell-derived cytokines such as thymic stromal lymphopoietin (TSLP), IL-33, and IL-25 ma
214 was associated with an increase in levels of thymic stromal lymphopoietin (TSLP), IL-9, and IL-13, bu
215 ative PCR was used to measure mRNA for sHBEC thymic stromal lymphopoietin (TSLP), IL33, POSTN, and IL
216 fic for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose a
218 rtinez-Cingolani et al identified that human thymic stromal lymphopoietin (TSLP), previously shown to
219 ns in receptors for interleukin-7 (IL-7) and thymic stromal lymphopoietin (TSLP), resulting in a nove
220 ons of the other innate cytokines, IL-33 and thymic stromal lymphopoietin (TSLP), to the observed ast
221 ytokines, interleukin-25 (IL-25), IL-33, and thymic stromal lymphopoietin (TSLP), which nonredundantl
222 Th2 central memory cells are stimulated with thymic stromal lymphopoietin (TSLP)-activated dendritic
223 etween classical IL-3-elicited basophils and thymic stromal lymphopoietin (TSLP)-elicited basophils.
238 Intestinal epithelial cells (IECs) produce thymic stromal lymphopoietin (TSLP); however, the in viv
239 ukin-4 (IL-4), IL-5, IL-9, IL-13, IL-31, and thymic stromal lymphopoietin (TSLP); pro-inflammatory cy
240 pithelial cell (EC)-derived cytokines (e.g., thymic stromal lymphopoietin [TSLP]) activating human ba
241 Epithelial cytokines (IL-33, IL-25, and thymic stromal lymphopoietin [TSLP]) and mast cell media
242 es usually undetectable on arrays (ie, IL22, thymic stromal lymphopoietin [TSLP], CCL22, and CCL26).
243 B cell progenitors seeded in the presence of thymic stromal lymphopoietin undergo significant expansi
245 helial expression of IL-25, but not IL-33 or thymic stromal lymphopoietin, was increased in a subset
248 In this article, we report that IL-33 and thymic stromal lymphopoietin were produced quickly in th
249 ucing cytokines, including interleukin 4 and thymic stromal lymphopoietin, which are involved in TH2
250 ucing cytokines, including interleukin 4 and thymic stromal lymphopoietin, which are involved in TH2
251 vitro scratch wound initiated the release of thymic stromal lymphopoietin, which was greater in epith
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。